Abstract |
Correlation between superlow-dose antibodies to endothelial NO synthase ( Impaza) and serum level of ADMA was evaluated in a double blind placebo-controlled study. The reduction of ADMA in patients with erectile dysfunction after impaza treatment was paralleled by improvement of clinical symptoms. No clear-cut correlation between ADMA level and impaza effect was detected.
|
Authors | E S Zhavbert, S A Tarasov, J L Dugina, S A Sergeeva, S I Gamidov, E B Mazo, O I Epstein |
Journal | Bulletin of experimental biology and medicine
(Bull Exp Biol Med)
Vol. 145
Issue 3
Pg. 367-70
(Mar 2008)
ISSN: 0007-4888 [Print] United States |
PMID | 19039946
(Publication Type: Controlled Clinical Trial, Journal Article)
|
Chemical References |
- Antibodies
- N,N-dimethylarginine
- Arginine
- Nitric Oxide Synthase Type III
|
Topics |
- Adult
- Antibodies
(therapeutic use)
- Arginine
(analogs & derivatives, blood)
- Double-Blind Method
- Erectile Dysfunction
(drug therapy)
- Humans
- Male
- Nitric Oxide Synthase Type III
(immunology)
|